Association Between Metabolic Obesity Phenotypes and the Risk of Developing Prostate Cancer: a Propensity Score Matching Study Based on Xinjiang

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Aug 21

PMID 39165513

Authors

Jinru Wang

Aireti Apizi

Hao Qiu

Ning Tao

Hengqing An

Affiliations

Soon will be listed here.

Abstract

Background: Obesity-induced metabolic dysfunction increases the risk of developing tumors, however, the relationship between metabolic obesity phenotypes and prostate cancer (PCa) remains unclear.

Methods: The term metabolic obesity phenotypes was introduced based on metabolic status and BMI categories. Participants were categorized into four groups: metabolically healthy nonobesity (MHNO), metabolically healthy obesity (MHO), metabolically unhealthy nonobesity (MUNO), and metabolically unhealthy obesity (MUO). Propensity score matching was conducted based on age, ethnicity, marriage, etc. Univariate and multivariate conditional logistic regression analyses were used to assess the relationship between metabolic obesity phenotypes, metabolic risk factors, and PCa. Sensitivity analysis was performed to verify the robustness of the results.

Results: After propensity score matching among 564 PCa patients and 1418 healthy individuals, 209 were selected for each of the case and control groups. There were no statistically significant differences in the basic characteristics between the two groups. Univariate and multivariate conditional logistic regression suggested that the risk of developing PCa in both MHO and MUO individuals was higher than in MHNO individuals. Specifically, the risk of developing PCa in MHO individuals was 2.166 times higher than in MHNO individuals (OR=2.166, 95%CI: 1.133-4.139), and the risk in MUO individuals was is 2.398 times higher than in MHNO individuals(OR=2.398, 95%CI:1.271-4.523). Individuals with hyperglycemia and elevated triglycerides also had a higher risk of developing PCa (hyperglycemia:OR=1.488, 95%CI: 1.001-2.210; elevated triglycerides: OR=2.292, 95%CI: 1.419-3.702). Those with more than or equal to three metabolic risk factors had an increased risk of PCa (OR=1.990, 95%CI: 1.166-3.396). Sensitivity analysis indicated an increased risk of PCa in MUO individuals compared to MHNO individuals.

Conclusion: In this retrospective study, individuals with MHO and MUO had a higher risk of developing PCa.

References

Wondmkun Y . Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications. Diabetes Metab Syndr Obes. 2020; 13:3611-3616. PMC: 7553667. DOI: 10.2147/DMSO.S275898. View

Sena C, Pereira A, Seica R . Endothelial dysfunction - a major mediator of diabetic vascular disease. Biochim Biophys Acta. 2013; 1832(12):2216-31. DOI: 10.1016/j.bbadis.2013.08.006. View

Sun K, Kusminski C, Scherer P . Adipose tissue remodeling and obesity. J Clin Invest. 2011; 121(6):2094-101. PMC: 3104761. DOI: 10.1172/JCI45887. View

Bell J, Hamer M, Sabia S, Singh-Manoux A, Batty G, Kivimaki M . The natural course of healthy obesity over 20 years. J Am Coll Cardiol. 2015; 65(1):101-102. DOI: 10.1016/j.jacc.2014.09.077. View

Paczkowska-Abdulsalam M, Kretowski A . Obesity, metabolic health and omics: Current status and future directions. World J Diabetes. 2021; 12(4):420-436. PMC: 8040086. DOI: 10.4239/wjd.v12.i4.420. View

Oh Y, Bae G, Baek D, Park E, Jun H . Fatty Acid-Induced Lipotoxicity in Pancreatic Beta-Cells During Development of Type 2 Diabetes. Front Endocrinol (Lausanne). 2018; 9:384. PMC: 6054968. DOI: 10.3389/fendo.2018.00384. View

Hammarsten J, Damber J, Haghsheno M, Mellstrom D, Peeker R . A stage-dependent link between metabolic syndrome components and incident prostate cancer. Nat Rev Urol. 2018; 15(5):321-333. DOI: 10.1038/nrurol.2018.8. View

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2001; 894:i-xii, 1-253. View

10.

Thomas D, Apovian C . Macrophage functions in lean and obese adipose tissue. Metabolism. 2017; 72:120-143. PMC: 5516622. DOI: 10.1016/j.metabol.2017.04.005. View

11.

Solinas C, Martinez Chanza N, Awada A, Scartozzi M . The immune infiltrate in prostate, bladder and testicular tumors: An old friend for new challenges. Cancer Treat Rev. 2017; 53:138-145. DOI: 10.1016/j.ctrv.2016.12.004. View

12.

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

13.

Zmuda J, Cauley J, Kriska A, Glynn N, Gutai J, Kuller L . Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol. 1997; 146(8):609-17. DOI: 10.1093/oxfordjournals.aje.a009326. View

14.

Tang H, Xiang Z, Li L, Shao X, Zhou Q, You X . Potential role of anti-inflammatory HDL subclasses in metabolic unhealth/obesity. Artif Cells Nanomed Biotechnol. 2021; 49(1):565-575. DOI: 10.1080/21691401.2021.1961798. View

15.

Kalle Kwaifa I, Bahari H, Yong Y, Md Noor S . Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications. Biomolecules. 2020; 10(2). PMC: 7072669. DOI: 10.3390/biom10020291. View

16.

Zhou B . Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002; 15(1):83-96. View

17.

Swinnen J, Heemers H, Van de Sande T, De Schrijver E, Brusselmans K, Heyns W . Androgens, lipogenesis and prostate cancer. J Steroid Biochem Mol Biol. 2005; 92(4):273-9. DOI: 10.1016/j.jsbmb.2004.10.013. View

18.

Pi X, Xie L, Patterson C . Emerging Roles of Vascular Endothelium in Metabolic Homeostasis. Circ Res. 2018; 123(4):477-494. PMC: 6205216. DOI: 10.1161/CIRCRESAHA.118.313237. View

19.

Crocetto F, Barone B, De Luca L, Creta M . Granulomatous prostatitis: a challenging differential diagnosis to take into consideration. Future Oncol. 2020; 16(13):805-806. DOI: 10.2217/fon-2020-0185. View

20.

Fuster J, Ouchi N, Gokce N, Walsh K . Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circ Res. 2016; 118(11):1786-807. PMC: 4887147. DOI: 10.1161/CIRCRESAHA.115.306885. View